Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03136913 · ClinicalTrials.gov registry record · NA
A Comparison Between Primary and Secondary Flap Coverage in Extraction Sites: A Pilot Study
A NA study of Loss of Teeth Due to Extraction, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT03136913: Completed NA study of Loss of Teeth Due to Extraction, sponsored by Tufts University.
NCT03136913 is a NA study of Loss of Teeth Due to Extraction that has completed, run by Tufts University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03136913, a NA study of Loss of Teeth Due to Extraction, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted to compare the outcomes of two separate surgical techniques used in tooth extraction and ridge preservation. Ridge preservation is done to potentially minimize the amount of bone loss that occurs between the tooth extraction and implant or bridge placement, as compared to leaving the extraction site empty. There are two techniques that are commonly used for these procedures, either to close the surgical site of the extracted tooth with sutures (closed flap technique) or to leave the extraction site open to heal naturally (open flap technique). In the open flap technique there will be sutures used to secure and hold down the material used to cover the wound, called a non-resorbable membrane. The flaps will remain in their natural position, the site will fill up naturally with new tissue from the bottom up and then close itself in from the sides. The investigators want to see which technique offers better healing and reduces bone loss.
Primary Outcome
Models/casts will be made in stone using the impressions. A stent will be made to measure the height and width of the alveolar ridge. Ridge height will be measured before tooth extraction, and 3-5 months after ridge preservation.
Conditions Studied
Interventions
- DEVICE Cytoplast® TXT-200
- DEVICE MinerOss® Cortical and Cancellous Chips (FDBA)
- PROCEDURE Open Flap Technique
- PROCEDURE Closed Flap Technique
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-02-17 |
| Est. Completion | 2016-10-11 |
| Phase | NA |
What the finished NCT03136913 record still lists
NCT03136913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Loss of Teeth Due to Extraction appearing as the primary indexed condition, and to 4 interventions - of which Cytoplast® TXT-200 is the first listed.
NCT03136913 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03136913 about?
NCT03136913 is a clinical study titled "A Comparison Between Primary and Secondary Flap Coverage in Extraction Sites: A Pilot Study". This study is being conducted to compare the outcomes of two separate surgical techniques used in tooth extraction and ridge preservation. Ridge preservation is done to potentially minimize the amount of bone loss that occurs between the tooth extraction and implant or bridge placement, as compared ...
What is the current status of trial NCT03136913?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2015-02-17. Estimated completion is 2016-10-11.
What conditions does trial NCT03136913 study?
This clinical trial studies the following conditions: Loss of Teeth Due to Extraction.
What interventions are being tested in trial NCT03136913?
The interventions under investigation include: Cytoplast® TXT-200 (DEVICE), MinerOss® Cortical and Cancellous Chips (FDBA) (DEVICE), Open Flap Technique (PROCEDURE), Closed Flap Technique (PROCEDURE).
Who is sponsoring clinical trial NCT03136913?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03136913 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03136913's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI